- What You Need to Know
- Getting Tested
- CDC Vaccine Data Tracker
Vaccine Rollout as of May 27:
Total Distributed: 20,215,485. Total Administered: 16,783,474.VA Vaccine DashboardCDC COVID-19 Vaccines
Visit your state's vaccine dashboard to learn more about their distribution guidelines. The CDC also has updated information on COVID-19 vaccines, including recommendations processes, differences about the different types, their benefits, safety data, and frequently asked questions.Crisis Text Line
- What You Need to Know
Jun 21, 2021 · Low-certainty evidence found that ivermectin prophylaxis reduced COVID-19 infection by an average 86% (95% confidence interval 79%–91%). Secondary outcomes provided less certain evidence.
- Andrew Bryant, Theresa A Lawrie, Therese Dowswell, Edmund J Fordham, Scott Mitchell, Sarah R Hill, T...
Ivermectin is approved for human use to treat infections caused by some parasitic worms and head lice and skin conditions like rosacea. Currently available data do not show ivermectin is effective...
Letter to the Editor: A recent study shows ivermectin is not an effective COVID-19 treatment
Two recent articles clarify Bruce Menzel’s late April letter asserting that use of ivermectin in COVID-19 infections is foolhardy. In toxicology, any medicine ...
Summit Daily News
5 days ago
- Proposed Mechanism of Action and Rationale For Use in Patients with Covid-19
- Monitoring, Adverse Effects, and Drug-Drug Interactions
- Clinical Trials
Reports from in vitro studies suggest that ivermectin acts by inhibiting host importin alpha/beta-1 nuclear transport proteins, which are part of a key intracellular transport process.3,4 Viruses hijack the process and enhance infection by suppressing the host’s antiviral response. In addition, ivermectin docking may interfere with SARS-CoV-2 spike...
The Panel recommends against the use of ivermectin for the treatment of COVID-19, except in clinical trials (AIIa).
The results of several randomized trials and retrospective cohort studies of ivermectin use in patients with COVID-19 have been published in peer-reviewed journals or have been made available as manuscripts ahead of peer review. Most of these studies, especially studies completed earlier in the pandemic, had incomplete information and significant m...Adverse effects of ivermectin may include dizziness, pruritis, nausea, or diarrhea.21Neurological adverse effects have been reported with the use of ivermectin for the treatment of onchocerciasis and other parasitic diseases, but it is not clear whether these adverse effects were c...Ivermectin is a minor cytochrome P450 3A4 substrate and a p-glycoprotein substrate.Ivermectin is generally given with water on an empty stomach; however, administering ivermectin with food increases its bioavailability.
Several clinical trials evaluating the use of ivermectin for the treatment of COVID-19 are currently underway or in development. Please see ClinicalTrials.govfor the latest information.
Oct 13, 2021 · The verdict so far is clear: Ivermectin, although it’s still being studied, “has not been found to be effective for the prevention of COVID-19 or the treatment of acute infection once it has...
- Theresa Tamkins
There were no severe adverse drug events recorded in the study. A 5-day course of ivermectin was found to be safe and effective in treating adult patients with mild COVID-19. Larger trials will be needed to confirm these preliminary findings.
- Sabeena Ahmed, Mohammad Mahbubul Karim, Allen G. Ross, Mohammad Sharif Hossain, John D. Clemens, Mar...
No study compared ivermectin to an intervention with proven efficacy. There were nine studies treating participants with moderate COVID-19 in inpatient settings and four treating mild COVID-19 cases in outpatient settings. One study investigated ivermectin for prevention of SARS-CoV-2 infection.